Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts): Contract Register & Procurement Profile
NHS ODS: NHS TRUST·NHS & health·Wales (Cymru)·Newport
Find a Tender organisation id104170
i
Tenders you can still bid for.
Notices at tender stage whose deadline has not passed, counted the way the search counts them: a notice shows under every code and region it names.
i
Notices published in the last 12 months.
Counted per tender, not per lot, against the 12 months before where shown.
i
How much of this buyer’s work goes to its three most frequent suppliers.
Share of its awarded tenders that name at least one of the top three. Each tender is counted once.
25 awarded tenders, 171 different suppliers.
Describes the record. It is not a sign of favouritism.
i
Contracts that finish in the next 18 months.
Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.
An end date does not confirm a new procurement.
i
How much this buyer has awarded recently, by published values.
Sum of published VAT-exclusive awards to single suppliers, last 24 months. Left out: concession revenue, framework ceilings, repeated notices, equal-value duplicates.
Published values, not actual spend. The biggest rows are listed so you can check.
What they buyi
What kind of work is bought here.
Notices by procurement category (CPV). A notice with several categories counts in each.
i
What kind of work is bought here.
Notices by procurement category (CPV). A notice with several categories counts in each.
Last 24 months · CPV divisions on published procedures · a notice with several divisions counts in each
33 Medical equipments, pharmaceuticals2 procedures · 100%How they buyi
How work here is packaged.
Notices by commercial tool: a single contract, a framework, or a dynamic purchasing system.
i
How work here is packaged.
Notices by commercial tool: a single contract, a framework, or a dynamic purchasing system.
Last 24 months · 2 notices · commercial tool and route as published on the notice, not a legal-regime claim
i
How work here is packaged.
Notices by commercial tool: a single contract, a framework, or a dynamic purchasing system.
Contract50%(1 notices)
1 of 2 notices are Contract (50%).Framework50%(1 notices)
1 of 2 notices are Framework (50%).
i
Which procedures buyers here use.
Notices by the procedure they declare: open, selective, limited or direct. Open and selective are competitions; limited and direct are not.
Open100%(2 notices)
2 of 2 notices are Open (100%).
i
How many companies usually bid when this buyer runs a tender.
Middle value of the bid counts on its award notices, one per lot. Only real competitions count: direct awards and framework places are left out.
Based on 1 lots from this buyer’s competitions, last 24 months. Small sample.
Who wins herei
Which suppliers win the most here.
Suppliers ranked by the number of tenders won, not by money. A supplier on one big framework with many call-offs does not outrank one that won many separate competitions.
i
Which suppliers win the most here.
Suppliers ranked by the number of tenders won, not by money. A supplier on one big framework with many call-offs does not outrank one that won many separate competitions.
All published awards naming a supplier · ranked by distinct procedures, not pounds · panel and call-off entries inflate award records
| Supplier | Procedures | Share | Last 24m | Award records | Last activity |
|---|---|---|---|---|---|
| Teva UK Ltd | 14 | 56% | 0 | 15 | — |
| ACCORD-UK LTD | 14 | 56% | 0 | 14 | — |
| Sandoz | 13 | 52% | 1 | 13 | — |
| Pfizer Ltd | 13 | 52% | 0 | 13 | — |
| Mylan | 12 | 48% | 0 | 12 | — |
| Mercury Pharmaceuticals Limited | 11 | 44% | 0 | 11 | — |
| Fresenius Kabi Limited | 10 | 40% | 1 | 10 | — |
| Kent Pharmaceuticals Ltd | 10 | 40% | 0 | 11 | — |
The three most frequent suppliers are named on 76% of 25 awarded procedures (each procedure counted once, so a panel shared by several of them is not double-counted); 171 distinct suppliers hold at least one. Descriptive concentration of published awards, not a statement of preference.
i
How much this buyer has awarded recently, by published values.
Sum of published VAT-exclusive awards to single suppliers, last 24 months. Left out: concession revenue, framework ceilings, repeated notices, equal-value duplicates.
Published values, not actual spend. The biggest rows are listed so you can check.
i
The middle published award value for this buyer.
Middle value of the same awards as the total above.
Largest published awards iThe biggest published awards. Awards to a single supplier with a published value, largest first, so you can check the totals against the notice. A repeated framework total can appear here. Open the notice to check. | Supplier | Awarded | Term | Published value |
|---|---|---|---|---|
| Transitional Drugs 3 | Sandoz | — | — | £7,180,657 † |
| Transitional Drugs 3 | Fresenius Kabi Limited | — | — | £5,963,560 † |
| Transitional Drugs 3 | Roche Products Ltd | — | — | £5,963,558 † |
| Transitional Drugs 3 | Amgen Ltd | — | — | £3,518,112 † |
| Transitional Drugs 3 | Celltrion Healthcare Uk Ltd | — | — | £3,388,055 † |
Contracts endingi
Contracts that finish in the next 18 months.
Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.
An end date does not confirm a new procurement.
i
Contracts that finish in the next 18 months.
Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.
An end date does not confirm a new procurement.
513 of 575 contracts carry an end date · not a retender forecast
| Contract | Holder | Ends | Published value |
|---|---|---|---|
| Generic Drugs - Tablets & Capsules | Abbvie Ltd | 31 Jan 2027 | £4,254 |
| Generic Drugs - Tablets & Capsules | Chiesi Limited | 31 Jan 2027 | £33,344 |
| Generic Drugs - Tablets & Capsules | Clydesdale Pharma ltd | 31 Jan 2027 | £12,190 |
| Generic Drugs - Tablets & Capsules | Colonis Pharma Ltd | 31 Jan 2027 | £193,672 |
| Generic Drugs - Tablets & Capsules | Crescent Pharma Limited | 31 Jan 2027 | £506,728 |
| Generic Drugs - Tablets & Capsules | CST Pharma Ltd | 31 Jan 2027 | £43,648 |
| Generic Drugs - Tablets & Capsules | Day Lewis Medical Ltd | 31 Jan 2027 | £187,660 |
| Generic Drugs - Tablets & Capsules | Dr Falk Pharma UK Ltd | 31 Jan 2027 | £47,800 |
| Generic Drugs - Tablets & Capsules | Dr Reddy's Laboratories (UK) Ltd | 31 Jan 2027 | £170,199 |
| Generic Drugs - Tablets & Capsules | DRUGSRUS LTD | 31 Jan 2027 | £707,827 |
Soonest 10 of 81 contracts ending within 18 months.
Recent procedures
Latest 28 of 28 procedures where this authority buys, is the authority the work is for, or runs the procurement
| Procedure | Status | Published | Published value |
|---|---|---|---|
| Aseptics Medicines (Including Cytotoxics)Pharmaceutical products | Awarded / complete | 31 Jul 2025 | £9,014,913 |
| Transitional Drugs 3Pharmaceutical products | Awarded / complete | 14 May 2025 | £15,169,777 |
| UstekinumbPharmaceutical products | Awarded / complete | 4 Apr 2025 | £6,069,376 |
| Unlicensed Medicines - Imports & SpecialsPharmaceutical products | Open | 20 Jan 2025 | — |
| Home Parenteral Nutrition ServicesHome medical treatment services | Awarded / complete | 25 Oct 2024 | — |
| Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)Pharmaceutical products | Awarded / complete | 9 Aug 2024 | — |
| Generic Drugs - Injections/InfusionsPharmaceutical products | Awarded / complete | 31 Jul 2024 | £15,382,134 |
| Generic Anti-Infective DrugsPharmaceutical products | Awarded / complete | 19 Mar 2024 | £3,390,876 |
| Generic Drugs - Tablets and CapsulesPharmaceutical products | Awarded / complete | 7 Mar 2024 | £18,165,923 |
| Transitional Drugs 2Pharmaceutical products | Awarded / complete | 15 Dec 2023 | £11,310,772 |
| Hepatitis C MedicinesPharmaceutical products | Awarded / complete | 9 Jun 2023 | — |
| Licensed Bulk MedicinesPharmaceutical products | Planned | 9 Jun 2023 | £42,317,737 |
| LenalidomidePharmaceutical products | Awarded / complete | 9 Dec 2022 | — |
| Transitional DrugsPharmaceutical products | Awarded / complete | 11 Oct 2022 | — |
| Generic Drugs - Injections/InfusionsPharmaceutical products | Awarded / complete | 3 Aug 2022 | — |
| Proprietary DrugsPharmaceutical products | Awarded / complete | 14 Jul 2022 | — |
| All Wales Low and Mid Tech Medicines Homecare ServicesHealth and social work services | Awarded / complete | 28 Apr 2022 | — |
| Generic Anti Infective DrugsPharmaceutical products | Awarded / complete | 16 Mar 2022 | £6,519,533 |
| IV Fluids & Irrigation SolutionsPharmaceutical products | Awarded / complete | 14 Mar 2022 | £4,207,485 |
| Generic Drugs - Tablets & CapsulesPharmaceutical products | Awarded / complete | 7 Mar 2022 | — |
About this data
- Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
- One profile per authority. Different spellings and registration numbers of the same body are merged into this profile. It includes tenders the authority ran for other bodies and tenders run on its behalf; spend is credited to the body that pays.
- Values are published values. Award values are what the authority published, excluding VAT and framework ceilings. They are not a budget or total spend.
- Contract end dates. 513 of 575 published contracts have an end date; 0 of those are estimated as the signature (or publication) date plus the published duration and are marked “estimated”. They feed “Contracts ending”, the same rule as the retender radar.
- Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.